Obesity Drugs Enjoy a Much-Needed Winning Str...

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. On this episode, hosts Carol Massar and Tim Stenovec speak to: Yoni Assia, eToro CEO on eToro's earnings, the retail trading space and how AI could b ...  Show more

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. On this episode of Bloomberg Businessweek Daily, hosts Carol Massar and Tim Stenovec speak with Bill Rauch and Zhailon Levingston, co-directors of 'C ...  Show more

Bloomberg Opinion Columnist and Former New York Fed President William Dudley discusses the outlook for the labor market and Fed monetary policy. David Riley, BlueBay Asset Management Chief Investment Strategist, says the market is underpricing the Fed. Danny Blanchflower, Dartmou ...  Show more

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Show more

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Show more

One of the most iconic brands in financial television returns for today's issues and today's world. This week's Wall Street Week features David Westin's interviews with Former Council of Economic Advisers Chairman Glenn Hubbard, Equity Group Investments Founder & Chairman Sam Zel ...  Show more